Acute rhinosinusitis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Your Organizational Guidance
ebpracticenet urges you to prioritize the following organizational guidance:
Richtlijn acute rinosinusitisPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2023Guide de pratique clinique rhinosinusite aiguëPublished by: Groupe de travail Développement de recommandations de première ligneLast published: 2023Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
suspected acute viral rhinosinusitis
supportive therapy
Viral rhinosinusitis is suspected when symptoms are stable and present for less than 10 days.
Generally a self-limiting disease, and treatment is primarily symptomatic.
Adequate rest and hydration and warm facial packs may be useful, as well as use of vitamin C and zinc.[4]Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464. https://www.rhinologyjournal.com/Documents/Supplements/supplement_29.pdf http://www.ncbi.nlm.nih.gov/pubmed/32077450?tool=bestpractice.com
Treatments should be tried for 5-10 days before reassessing the patient.
analgesic/antipyretic
Treatment recommended for SOME patients in selected patient group
Recommended for pain and/or fever. Selection of agent depends on the subjective level of pain the patient is experiencing.
Codeine is contraindicated in children younger than 12 years of age, and it is not recommended in adolescents 12 to 18 years of age who are obese or have conditions such as obstructive sleep apnea or severe lung disease as it may increase the risk of breathing problems.[32]US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Apr 2017 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children 12 years of age and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[33]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Jun 2013 [internet publication]. https://www.gov.uk/drug-safety-update/codeine-restricted-use-as-analgesic-in-children-and-adolescents-after-european-safety-review [34]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. Jun 2013 [internet publication]. https://www.ema.europa.eu/en/news/restrictions-use-codeine-pain-relief-children-cmdh-endorses-prac-recommendation
Primary options
acetaminophen: children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
acetaminophen/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 30-60 mg orally every 4-6 hours when required
More acetaminophen/codeineDose refers to codeine component. Maximum dose is based on acetaminophen component of 4000 mg/day (adults).
decongestant
Treatment recommended for SOME patients in selected patient group
May provide symptomatic relief of nasal congestion.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [15]Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-67. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Rhinitis-2020-A-practice-parameter-update.pdf http://www.ncbi.nlm.nih.gov/pubmed/32707227?tool=bestpractice.com
Topical agents (e.g., oxymetazoline) are often preferred over systemic agents (e.g., pseudoephedrine) because of increased potency and less risk of adverse effects.
Pseudoephedrine-containing medications are associated with a risk of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome. These are rare conditions with potentially serious and life-threatening complications. Pseudoephedrine-containing medications should not be used in patients with severe or uncontrolled hypertension, or those with severe acute or chronic renal disease or failure.[36]European Medicines Agency. Pseudoephedrine-containing medicinal products - referral. Mar 2024 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Topical agents should only be used for up to 3-5 days, to prevent the occurrence of rebound congestion.
Primary options
oxymetazoline nasal: children 2-5 years of age: (0.025%) 2-3 sprays/drops into each nostril twice daily when required; children >5 years of age and adults: (0.05%) 1-2 sprays/drops into each nostril twice daily when required
Secondary options
pseudoephedrine: adults: 30-60 mg orally every 4-6 hours when required, maximum 240 mg/day
intranasal corticosteroid
Treatment recommended for SOME patients in selected patient group
Recommended in patients with congestion. Considered beneficial and has a low incidence of systemic adverse effects.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39.
https://journals.sagepub.com/doi/full/10.1177/0194599815572097
http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com
[37]Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 Dec;116(6):1289-95.
https://www.jacionline.org/article/S0091-6749(05)01934-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16337461?tool=bestpractice.com
[38]Hayward G, Heneghan C, Perera R, et al. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med. 2012 May-Jun;10(3):241-9.
https://www.annfammed.org/content/10/3/241.long
http://www.ncbi.nlm.nih.gov/pubmed/22585889?tool=bestpractice.com
[39]Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 Dec 2;(12):CD005149.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005149.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/24293353?tool=bestpractice.com
[ ]
In people with acute sinusitis, what are the effects of intranasal corticosteroids?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.279/fullShow me the answer
At least 1 month of therapy is usually recommended; however, this will depend on the disease course.
Primary options
fluticasone propionate nasal: (50 micrograms/spray) children ≥4 years of age and adults: 1-2 sprays in each nostril once daily
OR
mometasone nasal: (50 micrograms/spray) children 2-11 years of age: 1 spray in each nostril once daily; children ≥12 years of age: 2 sprays in each nostril once daily; adults: 2 sprays in each nostril once or twice daily
OR
ciclesonide nasal: (50 micrograms/spray) children ≥6 years of age and adults: 2 sprays in each nostril once daily; (37 micrograms/spray) children ≥12 years of age and adults: 1 spray in each nostril once daily
ipratropium
Treatment recommended for SOME patients in selected patient group
Topical anticholinergics such as ipratropium can be used in patients with rhinorrhea.[40]AlBalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database Syst Rev. 2013 Jun 19;(6):CD008231. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008231.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23784858?tool=bestpractice.com
Primary options
ipratropium bromide nasal: children ≥6 years of age: (0.03%) 42 micrograms (2 sprays) in each nostril two or three times daily; adults: (0.06%) 84 micrograms (2 sprays) in each nostril three times daily
intranasal saline
Treatment recommended for SOME patients in selected patient group
Saline sprays may be useful for treating congestion by reducing inflammation and thinning mucus, and have the added advantage of decreasing medication use.
Saline nasal irrigations may be helpful in relieving nasal symptoms; however, they should be used cautiously as patients who have not had an endoscopic sinus surgery may develop facial pressure or discomfort when the saline irrigations get trapped in the nonoperated sinuses.[41]King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015 Apr 20;(4):CD006821. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006821.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/25892369?tool=bestpractice.com
A home-prepared saline irrigation may be helpful for patients. University of Michigan Health System: saltwater washes (nasal saline lavage or irrigation) for sinusitis Opens in new window
Primary options
saline nasal: children and adults: 1-2 sprays/drops into each nostril every 2-3 hours or when required
suspected acute bacterial rhinosinusitis
antibiotic therapy
Guidelines generally recommend antibiotic therapy for immunocompromised patients or those with severe illness. Indicators of severe illness include fever (>102.2°F [>39°C]); moderate to severe facial or dental pain; unilateral sinus tenderness; periorbital edema; worsening of symptoms after 3-5 days; or lack of improvement after 7-10 days of observation.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf [45]Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. http://www.ncbi.nlm.nih.gov/pubmed/18718440?tool=bestpractice.com [49]Harris AM, Hicks LA, Qaseem A; High Value Care Task Force of the ACP and the CDC. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016 Mar 15;164(6):425-34. https://www.acpjournals.org/doi/10.7326/M15-1840 http://www.ncbi.nlm.nih.gov/pubmed/26785402?tool=bestpractice.com
Although guidelines may vary in their recommendations for empiric antibiotics, studies have not demonstrated a difference in clinical outcomes between various antibiotic regimens.[51]Rosenfeld RM. Clinical Practice. Acute sinusitis in adults. N Engl J Med. 2016 Sep 8;375(10):962-70.
High-dose amoxicillin/clavulanate is recommended as a first-line agent for people who have severe disease or are immunocompromised, owing to the increased endemic rates of beta-lactamase-producing S pneumoniae.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com High-dose amoxicillin/clavulanate is effective against pneumococci of variable susceptibilities.[61]Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009 Mar;63(3):511-9. https://academic.oup.com/jac/article/63/3/511/693929 http://www.ncbi.nlm.nih.gov/pubmed/19174454?tool=bestpractice.com
For penicillin-allergic patients, a reasonable alternative is therapy with clindamycin plus an oral third-generation cephalosporin (e.g., cefixime, cefpodoxime).[2]Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. http://www.ncbi.nlm.nih.gov/pubmed/33236525?tool=bestpractice.com [54]Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr;54(8):e72-112. https://academic.oup.com/cid/article/54/8/1041/364141 http://www.ncbi.nlm.nih.gov/pubmed/22438350?tool=bestpractice.com There is a risk of cross-sensitivity with cephalosporins in these patients, although this risk is low if the allergic manifestation is simply a rash without respiratory involvement.[55]Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol. 2014 May;112(5):404-12.
Doxycycline is a suitable alternative in adults with allergies to beta-lactam antibiotics; however, its use is not recommended in children due to risk of tooth discoloration and dental enamel hypoplasia.[56]Gaillard T, Briolant S, Madamet M, et al. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017 Apr 13;16(1):148. https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-1797-9 http://www.ncbi.nlm.nih.gov/pubmed/28407772?tool=bestpractice.com
Fluoroquinolones should only be used in patients with acute bacterial rhinosinusitis who do not have other treatment options.[57]US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Jul 2016 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics They may be tried in adults if treatment with a penicillin or cephalosporin is not possible. Fluoroquinolones should be used with caution in children due to risk of musculoskeletal adverse effects.[58]Adefurin A, Sammons H, Jacqz-Aigrain E, et al. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011 Sep;96(9):874-80. https://adc.bmj.com/content/96/9/874.long http://www.ncbi.nlm.nih.gov/pubmed/21785119?tool=bestpractice.com Systemic fluoroquinolone antibiotics may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to, tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycemia; and central nervous system effects including seizures, depression, psychosis, and suicidal thoughts and behavior.[59]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056716 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug formulary for more information on suitability, contraindications, and precautions.
The recommended treatment course is unclear.[45]Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. http://www.ncbi.nlm.nih.gov/pubmed/18718440?tool=bestpractice.com However, 10-14 days is reasonable, particularly for immunocompromised patients or those with severe disease.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
If there is no improvement in symptoms after 3-5 days of antibiotic treatment, an alternative should be considered.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf Another consideration should be an ear, nose, and throat specialist consultation.
Intravenous antibiotics (e.g., third-generation cephalosporin, fluoroquinolone) may be required in patients with an infection that requires hospitalization.
Primary options
amoxicillin/clavulanate: children: 90 mg/kg/day orally given in 2 divided doses; adults: 2000 mg orally (extended-release) twice daily
More amoxicillin/clavulanateDose refers to amoxicillin component.
Secondary options
clindamycin: children: 30-40 mg/kg/day orally given in 3 divided doses; adults: 150-450 mg orally three times daily
-- AND --
cefixime: children: 8 mg/kg/day orally given in 1-2 divided doses; adults: 400 mg orally once daily
or
cefpodoxime proxetil: children: 10 mg/kg/day orally given in 2 divided doses; adults: 200 mg orally twice daily
OR
doxycycline: adults: 100 mg orally twice daily, or 200 mg orally once daily
OR
ceftriaxone: children: 50 mg/kg/day intravenously given in divided doses every 12 hours; adults: 1-2 g intravenously every 12-24 hours
OR
cefotaxime: children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4-6 hours
Tertiary options
moxifloxacin: children: consult specialist for guidance on dose; adults: 400 mg orally/intravenously once daily
OR
levofloxacin: children: consult specialist for guidance on dose; adults: 500 mg orally/intravenously once daily
ear, nose, and throat specialist referral
Treatment recommended for ALL patients in selected patient group
The specialist may adjust antibiotic therapy to cover less common causative microorganisms (e.g., add metronidazole or clindamycin to cover anaerobes), reevaluate the patient for underlying conditions or anatomic abnormalities, or consider surgery.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
supportive therapy
Treatment recommended for ALL patients in selected patient group
Adequate rest and hydration and warm facial packs may be useful, as well as use of vitamin C and zinc.[4]Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464. https://www.rhinologyjournal.com/Documents/Supplements/supplement_29.pdf http://www.ncbi.nlm.nih.gov/pubmed/32077450?tool=bestpractice.com Selection of therapy will depend on the specific symptoms.
analgesic/antipyretic
Treatment recommended for SOME patients in selected patient group
Recommended for pain and/or fever. Selection of agent depends on the subjective level of pain the patient is experiencing.
Codeine is contraindicated in children younger than 12 years of age, and it is not recommended in adolescents 12-18 years of age who are obese or have conditions such as obstructive sleep apnea or severe lung disease as it may increase the risk of breathing problems.[32]US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Apr 2017 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children 12 years of age and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[33]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Jun 2013 [internet publication]. https://www.gov.uk/drug-safety-update/codeine-restricted-use-as-analgesic-in-children-and-adolescents-after-european-safety-review [34]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. Jun 2013 [internet publication]. https://www.ema.europa.eu/en/news/restrictions-use-codeine-pain-relief-children-cmdh-endorses-prac-recommendation
Primary options
acetaminophen: children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
acetaminophen/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 30-60 mg orally every 4-6 hours when required
More acetaminophen/codeineDose refers to codeine component. Maximum dose is based on acetaminophen component of 4000 mg/day (adults).
decongestant
Treatment recommended for SOME patients in selected patient group
May provide symptomatic relief of nasal congestion.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com
Topical agents (e.g., oxymetazoline) are often preferred over systemic agents (e.g., pseudoephedrine) because of increased potency and less risk of adverse effects.
Pseudoephedrine-containing medications are associated with a risk of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome. These are rare conditions with potentially serious and life-threatening complications. Pseudoephedrine-containing medications should not be used in patients with severe or uncontrolled hypertension, or those with severe acute or chronic renal disease or failure.[36]European Medicines Agency. Pseudoephedrine-containing medicinal products - referral. Mar 2024 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Topical agents should only be used for up to 3-5 days, to prevent the occurrence of rebound congestion.
Primary options
oxymetazoline nasal: children 2-5 years of age: (0.025%) 2-3 sprays/drops into each nostril twice daily when required; children >5 years of age and adults: (0.05%) 1-2 sprays/drops into each nostril twice daily when required
Secondary options
pseudoephedrine: adults: 30-60 mg orally every 4-6 hours when required, maximum 240 mg/day
intranasal corticosteroid
Treatment recommended for SOME patients in selected patient group
Recommended in patients with congestion.
Considered beneficial and has a low incidence of systemic adverse effects.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39.
https://journals.sagepub.com/doi/full/10.1177/0194599815572097
http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com
[37]Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 Dec;116(6):1289-95.
https://www.jacionline.org/article/S0091-6749(05)01934-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16337461?tool=bestpractice.com
[39]Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 Dec 2;(12):CD005149.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005149.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/24293353?tool=bestpractice.com
[ ]
In people with acute sinusitis, what are the effects of intranasal corticosteroids?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.279/fullShow me the answer
At least 1 month of therapy is usually recommended; however, this will depend on the disease course.
Primary options
fluticasone propionate nasal: (50 micrograms/spray) children ≥4 years of age and adults: 1-2 sprays in each nostril once daily
OR
mometasone nasal: (50 micrograms/spray) children 2-11 years of age: 1 spray in each nostril once daily; children ≥12 years of age: 2 sprays in each nostril once daily; adults: 2 sprays in each nostril once or twice daily
OR
ciclesonide nasal: (50 micrograms/spray) children ≥6 years of age and adults: 2 sprays in each nostril once daily; (37 micrograms/spray) children ≥12 years of age and adults: 1 spray in each nostril once daily
intranasal saline
Treatment recommended for SOME patients in selected patient group
Saline sprays may be useful for treating congestion by reducing inflammation and thinning mucus, and have the added advantage of decreasing medication use.
Saline nasal irrigations may be helpful in relieving nasal symptoms; however, they should be used cautiously as patients who have not had an endoscopic sinus surgery may develop facial pressure or discomfort when the saline irrigations get trapped in the nonoperated sinuses.[41]King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015 Apr 20;(4):CD006821. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006821.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/25892369?tool=bestpractice.com
A home-prepared saline irrigation may be helpful for patients. University of Michigan Health System: saltwater washes (nasal saline lavage or irrigation) for sinusitis Opens in new window
Primary options
saline nasal: children and adults: 1-2 sprays/drops into each nostril every 2-3 hours or when required
watchful waiting for up to 10 days, or immediate commencement of antibiotics, and supportive therapy
Some guidelines recommend watchful waiting for up to 10 days with symptomatic therapy before instituting subsequent antibiotic therapy, as the majority of nonsevere cases will resolve without them.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [44]Guarch Ibáñez B, Buñuel Álvarez JC, López Bermejo A, et al. The role of antibiotics in acute sinusitis: a systematic review and meta-analysis [in Spanish]. An Pediatr (Barc). 2011 Mar;74(3):154-60. http://www.ncbi.nlm.nih.gov/pubmed/21237732?tool=bestpractice.com However, immediate antibiotic therapy can shorten the duration of symptoms, so may be used if the benefits (i.e., eradication of infection, improvement in symptoms, reduced duration of illness) outweigh the risks (i.e., adverse effects, cost, need for follow-up, increased bacterial resistance) of therapy.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf [45]Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. http://www.ncbi.nlm.nih.gov/pubmed/18718440?tool=bestpractice.com
For supportive therapy, adequate rest and hydration and warm facial packs may be useful, as well as use of vitamin C and zinc.[4]Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464. https://www.rhinologyjournal.com/Documents/Supplements/supplement_29.pdf http://www.ncbi.nlm.nih.gov/pubmed/32077450?tool=bestpractice.com Selection of therapy will depend on the specific symptoms.
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Antibiotics are not usually recommended immediately in patients who are immunocompetent and who have nonsevere illness (i.e., absence of fever, mild facial or dental pain), as the majority of cases will resolve without them.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [44]Guarch Ibáñez B, Buñuel Álvarez JC, López Bermejo A, et al. The role of antibiotics in acute sinusitis: a systematic review and meta-analysis [in Spanish]. An Pediatr (Barc). 2011 Mar;74(3):154-60. http://www.ncbi.nlm.nih.gov/pubmed/21237732?tool=bestpractice.com
However, immediate antibiotic therapy can shorten the duration of symptoms, so may be used if the benefits (i.e., eradication of infection, improvement in symptoms, reduced duration of illness) outweigh the risks (i.e., adverse effects, cost, need for follow-up, increased bacterial resistance) of therapy.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf [45]Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. http://www.ncbi.nlm.nih.gov/pubmed/18718440?tool=bestpractice.com
Amoxicillin or amoxicillin/clavulanate has generally been recommended as a first-line agent for nonsevere disease in immunocompetent people, owing to its safety, efficacy, and low cost.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com One pediatric cohort study found there was no difference in treatment failure rates between the use of amoxicillin or amoxicillin/clavulanate for acute rhinosinusitis, but amoxicillin/clavulanate was associated with a higher risk of gastrointestinal symptoms and yeast infections.[52]Savage TJ, Kronman MP, Sreedhara SK, et al. Treatment failure and adverse events after amoxicillin-clavulanate vs amoxicillin for pediatric acute sinusitis. JAMA. 2023 Sep 19;330(11):1064-73. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509725 http://www.ncbi.nlm.nih.gov/pubmed/37721610?tool=bestpractice.com
For penicillin-allergic patients, a reasonable alternative is therapy with clindamycin plus third-generation cephalosporin (e.g., cefuroxime, cefpodoxime).[2]Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. http://www.ncbi.nlm.nih.gov/pubmed/33236525?tool=bestpractice.com [54]Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr;54(8):e72-112. https://academic.oup.com/cid/article/54/8/1041/364141 http://www.ncbi.nlm.nih.gov/pubmed/22438350?tool=bestpractice.com There is a risk of cross-sensitivity with cephalosporins in these patients, although this risk is low if the allergic manifestation is simply a rash without respiratory involvement.[55]Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol. 2014 May;112(5):404-12.
Doxycycline is a suitable alternative in adults with allergies to beta-lactam antibiotics; however, its use is not recommended in children due to risk of tooth discoloration and dental enamel hypoplasia.[56]Gaillard T, Briolant S, Madamet M, et al. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017 Apr 13;16(1):148. https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-1797-9 http://www.ncbi.nlm.nih.gov/pubmed/28407772?tool=bestpractice.com
Fluoroquinolones should not be used in nonsevere infections.[58]Adefurin A, Sammons H, Jacqz-Aigrain E, et al. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011 Sep;96(9):874-80. https://adc.bmj.com/content/96/9/874.long http://www.ncbi.nlm.nih.gov/pubmed/21785119?tool=bestpractice.com [67]Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Mar 2019 [internet publication]. https://www.gov.uk/drug-safety-update/fluoroquinolone-antibiotics-new-restrictions-and-precautions-for-use-due-to-very-rare-reports-of-disabling-and-potentially-long-lasting-or-irreversible-side-effects
The recommended treatment course is unclear.[45]Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. http://www.ncbi.nlm.nih.gov/pubmed/18718440?tool=bestpractice.com However, a 5-7 day course for adults and 10-14 day course for children is reasonable.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf [60]National Institute for Health and Care Excellence. Sinusitis (acute): antimicrobial prescribing. Oct 2017 [internet publication]. https://www.nice.org.uk/guidance/ng79 [Evidence A]87b300ad-9897-45e1-8663-d5797a810ae3guidelineAWhat are the effects of short-course antibiotics versus long-course antibiotics in people with acute sinusitis?[60]National Institute for Health and Care Excellence. Sinusitis (acute): antimicrobial prescribing. Oct 2017 [internet publication]. https://www.nice.org.uk/guidance/ng79
If there is no improvement in symptoms after 3-5 days of treatment, an alternative antibiotic should be considered.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf Another consideration should be an ear, nose, and throat specialist consultation.
Primary options
amoxicillin: children: 45-90 mg/kg/day orally given in 2 divided doses; adults: 500-1000 mg orally three times daily, or 875 mg orally twice daily
OR
amoxicillin/clavulanate: children: 45-90 mg/kg/day orally given in 2 divided doses; adults: 500-875 mg orally twice daily, or 2000 mg orally (extended-release) twice daily
More amoxicillin/clavulanateDose refers to amoxicillin component.
Secondary options
clindamycin: children: 30-40 mg/kg/day orally given in 3 divided doses; adults: 150-450 mg orally three times daily
-- AND --
cefuroxime axetil: children: 30 mg/kg/day orally given in 2 divided doses; adults: 250-500 mg orally twice daily
or
cefpodoxime proxetil: children: 10 mg/kg/day orally given in 2 divided doses; adults: 200 mg orally twice daily
OR
doxycycline: adults: 100 mg orally twice daily, or 200 mg orally once daily
analgesic/antipyretic
Treatment recommended for SOME patients in selected patient group
Recommended for pain and/or fever. Selection of agent depends on the subjective level of pain the patient is experiencing.
Codeine is contraindicated in children younger than 12 years of age, and it is not recommended in adolescents 12-18 years of age who are obese or have conditions such as obstructive sleep apnea or severe lung disease as it may increase the risk of breathing problems.[32]US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Apr 2017 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children 12 years of age and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[33]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Jun 2013 [internet publication]. https://www.gov.uk/drug-safety-update/codeine-restricted-use-as-analgesic-in-children-and-adolescents-after-european-safety-review [34]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. Jun 2013 [internet publication]. https://www.ema.europa.eu/en/news/restrictions-use-codeine-pain-relief-children-cmdh-endorses-prac-recommendation
Primary options
acetaminophen: children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
acetaminophen/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 30-60 mg orally every 4-6 hours when required
More acetaminophen/codeineDose refers to codeine component. Maximum dose is based on acetaminophen component of 4000 mg/day (adults).
decongestant
Treatment recommended for SOME patients in selected patient group
May provide symptomatic relief of nasal congestion.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [15]Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-67. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Rhinitis-2020-A-practice-parameter-update.pdf http://www.ncbi.nlm.nih.gov/pubmed/32707227?tool=bestpractice.com
Topical agents (e.g., oxymetazoline) are often preferred over systemic agents (e.g., pseudoephedrine) because of increased potency and less risk of adverse effects.
Pseudoephedrine-containing medications are associated with a risk of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome. These are rare conditions with potentially serious and life-threatening complications. Pseudoephedrine-containing medications should not be used in patients with severe or uncontrolled hypertension, or those with severe acute or chronic renal disease or failure.[36]European Medicines Agency. Pseudoephedrine-containing medicinal products - referral. Mar 2024 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Topical agents should only be used for up to 3-5 days, to prevent the occurrence of rebound congestion.
Primary options
oxymetazoline nasal: children 2-5 years of age: (0.025%) 2-3 sprays/drops into each nostril twice daily when required; children >5 years of age and adults: (0.05%) 1-2 sprays/drops into each nostril twice daily when required
Secondary options
pseudoephedrine: adults: 30-60 mg orally every 4-6 hours when required, maximum 240 mg/day
intranasal corticosteroid
Treatment recommended for SOME patients in selected patient group
Recommended in patients with congestion.
Considered beneficial and has a low incidence of systemic adverse effects.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39.
https://journals.sagepub.com/doi/full/10.1177/0194599815572097
http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com
[37]Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 Dec;116(6):1289-95.
https://www.jacionline.org/article/S0091-6749(05)01934-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16337461?tool=bestpractice.com
[39]Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 Dec 2;(12):CD005149.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005149.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/24293353?tool=bestpractice.com
[ ]
In people with acute sinusitis, what are the effects of intranasal corticosteroids?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.279/fullShow me the answer
At least 1 month of therapy is usually recommended; however, this will depend on the disease course.
Primary options
fluticasone propionate nasal: (50 micrograms/spray) children ≥4 years of age and adults: 1-2 sprays in each nostril once daily
OR
mometasone nasal: (50 micrograms/spray) children 2-11 years of age: 1 spray in each nostril once daily; children ≥12 years of age: 2 sprays in each nostril once daily; adults: 2 sprays in each nostril once or twice daily
OR
ciclesonide nasal: (50 micrograms/spray) children ≥6 years of age and adults: 2 sprays in each nostril once daily; (37 micrograms/spray) children ≥12 years of age and adults: 1 spray in each nostril once daily
intranasal saline
Treatment recommended for SOME patients in selected patient group
Saline sprays may be useful for treating congestion by reducing inflammation and thinning mucus, and have the added advantage of decreasing medication use.
Saline nasal irrigations may be helpful in relieving nasal symptoms; however, they should be used cautiously as patients who have not had an endoscopic sinus surgery may develop facial pressure or discomfort when the saline irrigations get trapped in the nonoperated sinuses.[41]King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015 Apr 20;(4):CD006821. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006821.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/25892369?tool=bestpractice.com
A home-prepared saline irrigation may be helpful for patients. University of Michigan Health System: saltwater washes (nasal saline lavage or irrigation) for sinusitis Opens in new window
Primary options
saline nasal: children and adults: 1-2 sprays/drops into each nostril every 2-3 hours or when required
ear, nose, and throat (ENT) specialist referral
Treatment recommended for SOME patients in selected patient group
Patients should be referred to an ENT specialist when condition is refractory to usual antibiotic treatment.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
The specialist may adjust antibiotic therapy to cover less common causative microorganisms (e.g., add metronidazole or clindamycin to cover anaerobes), reevaluate the patient for underlying conditions or anatomic abnormalities, or consider surgery.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
suspected acute invasive fungal rhinosinusitis
immediate ear, nose, and throat specialist referral
Acute invasive fungal rhinosinusitis is a rare, rapidly progressive and life-threatening infection with a high mortality rate warranting immediate emergency referral and ENT consultation. Management consists of surgical debridement, systemic antifungal therapy, and correction of predisposing conditions.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf [66]Ahmed Y, Delaney S, Markarian A. Successful isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome. Am J Otolaryngol. 2015 Dec 9;37(2):152-5. http://www.ncbi.nlm.nih.gov/pubmed/26954873?tool=bestpractice.com
recurrent episodes
ear, nose, and throat (ENT) specialist referral
Patients should be referred to an ENT specialist when condition is recurrent (i.e., 4 or more episodes per year) or significantly affects quality of life.[1]Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39. https://journals.sagepub.com/doi/full/10.1177/0194599815572097 http://www.ncbi.nlm.nih.gov/pubmed/25832968?tool=bestpractice.com [3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
The specialist may adjust antibiotic therapy to cover less common causative microorganisms (e.g., add metronidazole or clindamycin to cover anaerobes), reevaluate the patient for underlying conditions or anatomic abnormalities, or consider surgery.[3]Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/2014-October_Rhinosinusitis_Update-(1).pdf
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer